TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Paragon Care Limited ( (AU:PGC) ) has issued an update.
Paragon Care Limited held its 2025 Annual General Meeting, where all resolutions, including the adoption of the remuneration report, election and re-election of directors, adoption of an omnibus equity plan, and issuance of performance rights to the CEO, were carried with overwhelming support. This indicates strong shareholder confidence in the company’s leadership and strategic direction, potentially strengthening its position in the healthcare industry.
The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is an Australian-based company in the healthcare sector, providing medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional supplies, and manufacturing Blood Bank diagnostic reagents. The company serves healthcare markets in Australia, New Zealand, and Asia.
Average Trading Volume: 569,080
Technical Sentiment Signal: Sell
Current Market Cap: A$521.4M
For detailed information about PGC stock, go to TipRanks’ Stock Analysis page.